.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Dow
Cerilliant
Fish and Richardson
Express Scripts
Healthtrust
Chubb
QuintilesIMS
Harvard Business School
McKinsey
Merck

Generated: December 18, 2017

DrugPatentWatch Database Preview

Orit Labs Llc Company Profile

« Back to Dashboard

What is the competitive landscape for ORIT LABS LLC, and what generic and branded alternatives to ORIT LABS LLC drugs are available?

ORIT LABS LLC has seven approved drugs.



Summary for Orit Labs Llc

US Patents:0
Tradenames:7
Ingredients:7
NDAs:7
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Orit Labs LlcMETRONIDAZOLEmetronidazoleTABLET;ORAL208681-001Jun 20, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcERGOCALCIFEROLergocalciferolCAPSULE;ORAL040833-001May 20, 2009AARXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcCLINDAMYCIN PALMITATE HYDROCHLORIDEclindamycin palmitate hydrochlorideFOR SOLUTION;ORAL206958-001May 5, 2017AARXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcMETRONIDAZOLEmetronidazoleTABLET;ORAL208681-002Jun 20, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcCYCLOBENZAPRINE HYDROCHLORIDEcyclobenzaprine hydrochlorideTABLET;ORAL078218-001Apr 18, 2008ABRXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcBISOPROLOL FUMARATEbisoprolol fumarateTABLET;ORAL204891-001Jan 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcBENZONATATEbenzonatateCAPSULE;ORAL040682-002Jul 30, 2007AARXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcBISOPROLOL FUMARATEbisoprolol fumarateTABLET;ORAL204891-002Jan 11, 2017ABRXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcLEVETIRACETAMlevetiracetamSOLUTION;ORAL203067-001May 9, 2013AARXNoNo► Subscribe► Subscribe► Subscribe
Orit Labs LlcCYCLOBENZAPRINE HYDROCHLORIDEcyclobenzaprine hydrochlorideTABLET;ORAL078218-002Jun 19, 2015ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Cipla
McKesson
Fish and Richardson
Baxter
Cerilliant
Novartis
US Department of Justice
QuintilesIMS
Chinese Patent Office
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot